LPL Financial
ATOS icon

LPL Financial’s Atossa Therapeutics ATOS Stock Holding History

LPL Financial’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,965
Closed -$17.4K – 5975
2025
Q4 		$17.4K Buy
1,965
+61
+3% +$771 ﹤0.01% 5818
2025
Q3 		$24.8K Buy
1,904
+47
+3% +$580 ﹤0.01% 5718
2025
Q2 		$23.1K Sell
1,857
-13
-0.7% -$155 ﹤0.01% 5455
2025
Q1 		$18.9K Sell
1,870
-93
-5% -$1.13K ﹤0.01% 5264
2024
Q4 		$27.8K Sell
1,963
-1,064
-35% -$20.8K ﹤0.01% 5165
2024
Q3 		$69K Sell
3,027
-7
-0.2% -$141 ﹤0.01% 4953
2024
Q2 		$54.2K Sell
3,034
-16
-0.5% -$354 ﹤0.01% 4830
2024
Q1 		$82.4K Sell
3,050
-83
-3% -$1.33K ﹤0.01% 4708
2023
Q4 		$41.4K Sell
3,133
-200
-6% -$2.16K ﹤0.01% 4672
2023
Q3 		$36.8K Buy
3,333
+200
+6% +$2.9K ﹤0.01% 4552
2023
Q2 		$59.2K Buy
+3,133
New +$38K ﹤0.01% 4404

Other funds holding ATOS

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

LPL Financial's ATOS Position: Q1 2026 in Review

LPL Financial sold out of Atossa Therapeutics (ATOS) in Q1 2026, closing a stake of 1,965 shares — an estimated $17.4K sold.

LPL Financial first reported a position in ATOS in Q2 2023 and held it in 11 quarters. The position peaked at $82.4K in Q1 2024. 33 funds tracked by Wall St. Rank hold ATOS as of Q1 2026.

  • LPL Financial reported no remaining Atossa Therapeutics position as of Q1 2026 after selling out during the quarter.
  • LPL Financial sold 1,965 Atossa Therapeutics shares in Q1 2026, an estimated $17.4K.
  • LPL Financial first reported a position in Atossa Therapeutics in Q2 2023 and held it in 11 quarters.
  • LPL Financial's Atossa Therapeutics position peaked at $82.4K in Q1 2024.
  • 33 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.